{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T23:00:46Z","timestamp":1700694046764},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00543334","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T02:38:29Z","timestamp":1100831909000},"page":"339-345","source":"Crossref","is-referenced-by-count":12,"title":["Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration"],"prefix":"10.1007","volume":"28","author":[{"given":"L. J.","family":"Lesko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. K.","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Yeager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. R.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0025-7125(16)32910-8","volume":"52","author":"TB Bayles","year":"1969","unstructured":"Bayles TB (1969) Salicylate therapy in rheumatoid arthritis. Med Clin North Am 52: 703?706","journal-title":"Med Clin North Am"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0003-2697(68)90039-0","volume":"26","author":"WF Blatt","year":"1968","unstructured":"Blatt WF, Robinson SM, Bixler JJ (1968) Membrane ultrafiltration: the diafiltration technique and its application to microsolute exchange and binding phenomena. Anal Biochem 26: 151?173","journal-title":"Anal Biochem"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/cpt1976204464","volume":"20","author":"O Borga","year":"1976","unstructured":"Borga O, Odar-Cederlof I, Ringberger V, Norlin A (1976) Protein binding of salicylate in uremic and normal plasma. Clin Pharmacol Ther 20: 464?475","journal-title":"Clin Pharmacol Ther"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jps.2600630215","volume":"63","author":"DS Campion","year":"1974","unstructured":"Campion DS, Olsen R (1974) Measurement of drug displacement by continuous ultrafiltration. J Pharm Sci 63: 247?252","journal-title":"J Pharm Sci"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.1780250105","volume":"25","author":"PB Costello","year":"1982","unstructured":"Costello PB, Green FA, Jung CY (1982) Free versus bound salicylate concentration in adults and children with chronic inflammatory joint disease. Arthritis Rheum 25: 32?37","journal-title":"Arthritis Rheum"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000212320","volume":"25","author":"G Cuny","year":"1979","unstructured":"Cuny G, Royer RJ, Mur JM, Serot JM, Faure G, Netten P, Maillard A, Pein F (1979) Pharmacokinetics of salicylates in the elderly. Gerontology 25: 49?55","journal-title":"Gerontology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00003088-197904020-00006","volume":"4","author":"R Ekstrand","year":"1979","unstructured":"Ekstrand R, Alvan G, Borga O (1979) Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clin Pharmacokin et 4: 137?143","journal-title":"Clin Pharmacokin et"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/cpt1979263380","volume":"26","author":"DE Furst","year":"1979","unstructured":"Furst DE, Tozer TN, Melmon KL (1979) Salicylate clearance, the resultant of protein binding and metabolism. Clin Pharmacol Ther 26: 380?389","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/0006-2952(79)90691-9","volume":"28","author":"R Geddes","year":"1978","unstructured":"Geddes R, White PM (1978) Drug binding in human serum albumin as assayed by diafiltration and fluorimetry. Biochem Pharmacol 28: 2285?2288","journal-title":"Biochem Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1528-1157.1979.tb04808.x","volume":"20","author":"L Gram","year":"1979","unstructured":"Gram L, Flachs H, Wurtz-Jorgensen A, Parnas J, Anderson B (1979) Sodium valproate, serum level and clinical effect in epilepsy: a controlled study. Epilepsia 20: 303?313","journal-title":"Epilepsia"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1532-5415.1979.tb01715.x","volume":"27","author":"DJ Greenblatt","year":"1979","unstructured":"Greenblatt DJ (1979) Reduced serum albumin concentration in the elderly: a report from the Boston Collaborative Drug Surveillance Program. J Am Geriatr Soc 27: 20?22","journal-title":"J Am Geriatr Soc"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM198205063061804","volume":"306","author":"DJ Greenblatt","year":"1982","unstructured":"Greenblatt DJ, Sellers EM, Shader RI (1982) Drug disposition in old age. N Engl J Med 306: 1081?1088","journal-title":"N Engl J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/j.1552-4604.1982.tb02671.x","volume":"22","author":"DJ Greenblatt","year":"1982","unstructured":"Greenblatt DJ, Sellers EM, Koch-Weser J (1982) Importance of protein binding for the interpretation of serum or plasma drug concentrations. J Clin Pharmacol 22: 259?263","journal-title":"J Clin Pharmacol"},{"key":"CR14","first-page":"117","volume":"6","author":"DS Greene","year":"1976","unstructured":"Greene DS, Nightingale CH (1976) A new method of calculating protein binding parameters obtained from diafiltration methods. Acad Pharm Sci Abstr 6: 117","journal-title":"Acad Pharm Sci Abstr"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2125.1975.tb00474.x","volume":"2","author":"MJ Hayes","year":"1975","unstructured":"Hayes MJ, Langman MJS, Short AH (1975) Changes in drug metabolism with increasing age; 1. Warfarin binding and plasma proteins. Br J Clin Pharmacol 2: 69?72","journal-title":"Br J Clin Pharmacol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.6287580","volume":"217","author":"I Klotz","year":"1982","unstructured":"Klotz I (1982) Number of receptor sites from Scatchard graphs: facts and fantasies. Science 217: 1347?1349","journal-title":"Science"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jps.2600540703","volume":"54","author":"G Levy","year":"1965","unstructured":"Levy G (1965) Pharmacokinetics of salicylate elimination in man. J Pharm Sci 54: 959?967","journal-title":"J Pharm Sci"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cpt197517121","volume":"17","author":"LE Mather","year":"1975","unstructured":"Mather LE, Tucker GT, Pflug AE, Linorop MJ, Wilkerson C (1975) Meperidine kinetics in man; intravenous injection in surgical patients and volunteers. Clin Pharmacol Ther 17: 21?30","journal-title":"Clin Pharmacol Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1016\/S0021-9258(18)61998-2","volume":"246","author":"RH McMenamy","year":"1971","unstructured":"McMenamy RH, Dintzis HM, Watson F (1971) Cyanogen bromide fragments of human serum albumin. J Biol Chem 246: 4744?4750","journal-title":"J Biol Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01059439","volume":"7","author":"PJ Meffin","year":"1979","unstructured":"Meffin PJ, Robert RW, Windle RA, Harapat S, Peters FA, Harrison DC (1979) Role of concentration dependent plasma protein binding in disopyramide disposition. J Pharmacokinet Biopharm 7: 29?46","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM196509092731104","volume":"273","author":"EN Meyers","year":"1965","unstructured":"Meyers EN, Bernstein JM, Fostiropolous G (1965) Salicylate ototoxicity. N Engl J Med 273: 587?590","journal-title":"N Engl J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/jps.2600670852","volume":"67","author":"AK Miller","year":"1978","unstructured":"Miller AK, Adir J, Vestal RE (1978) Tolbutamide binding to plasma proteins of young and old human subjects. J Pharm Sci 67: 1192?1193","journal-title":"J Pharm Sci"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.1973.03230020014004","volume":"226","author":"E Morgan","year":"1973","unstructured":"Morgan E, Kelly P, Nies K, Porter WW, Paulus HE (1973) Tinnitus as an indicator of therapeutic serum salicylate levels. J Am Med Assoc 226: 142?145","journal-title":"J Am Med Assoc"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-95-6-711","volume":"95","author":"J Ouslander","year":"1981","unstructured":"Ouslander J (1981) Drug therapy in the elderly. Ann Intern Med 95: 711?722","journal-title":"Ann Intern Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0021-9150(83)90160-0","volume":"46","author":"L Pickart","year":"1983","unstructured":"Pickart L (1983) Increased ratio of plasma free fatty acids during normal aging and in patients with coronary heart disease. Atherosclerosis 46: 21?28","journal-title":"Atherosclerosis"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.2042-7158.1983.tb04282.x","volume":"35","author":"GM Rubin","year":"1983","unstructured":"Rubin GM, Tozer TN, Oie S (1983) Concentration dependence of salicylate distribution. J Pharm Pharmacol 35: 115?117","journal-title":"J Pharm Pharmacol"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","volume":"51","author":"G Scatchard","year":"1949","unstructured":"Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660?672","journal-title":"Ann NY Acad Sci"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/jps.2600691129","volume":"69","author":"PA Schwartz","year":"1980","unstructured":"Schwartz PA, Greene DS, Rhodes CT (1980) Effect of sodium oleate on salicylic acid binding to human serum albumin. J Pharm Sci 69: 1345?1347","journal-title":"J Pharm Sci"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/jps.2600630905","volume":"63","author":"VP Shah","year":"1974","unstructured":"Shah VP, Wallace SM, Riegelman S (1974) Microultrafiltration technique for drug-protein binding determination in plasma. J Pharm Sci 63: 1364?1367","journal-title":"J Pharm Sci"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00716368","volume":"13","author":"WH Steele","year":"1978","unstructured":"Steele WH, Boobis SW, Moore MR, Goldberg A, Brodie MJ (1978) Protein binding of salicylate in cutaneous hepatic porphyria. Eur J Clin Pharmacol 13: 309?313","journal-title":"Eur J Clin Pharmacol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2125.1976.tb00611.x","volume":"3","author":"S Wallace","year":"1976","unstructured":"Wallace S, Whiting B (1976) Factors affecting drug binding in plasma of elderly patients. Br J Clin Pract 3: 327?330","journal-title":"Br J Clin Pract"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00561662","volume":"9","author":"WD Wosilait","year":"1976","unstructured":"Wosilait WD (1976) Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels. Eur J Clin Pharmacol 9: 285?290","journal-title":"Eur J Clin Pharmacol"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/0006-2952(74)90403-1","volume":"23","author":"JF Zaroslinski","year":"1974","unstructured":"Zaroslinski JF, Keresztes-Nagy S, Mais RF, Oester YT (1974) The effect of temperature on the binding of salicylate by human serum albumin. Biochem Pharmacol 23: 1767?1776","journal-title":"Biochem Pharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00543334.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00543334\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00543334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T02:39:24Z","timestamp":1624934364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00543334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00543334"],"URL":"https:\/\/doi.org\/10.1007\/bf00543334","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}